1. Van Ganse E., Laforest L., Pietri G. et al. Persistent asthma: disease control, resource utilisation and direct costs. Eur. Respir. J. 2002; 20: 260-267.
2. Gendo K., Lodewick M.J. Asthma economics: focusing on therapies that improve costly or outcomes. Curr. Opin. Pulm. Med. 2005; 11: 43-50.
3. Rabe K.F., Adachi M., Lai C.K. et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J. Allergy Clin. Immunol. 2004; 114: 40-47.
4. Бримкулов Н.Н. Пульмонология в Кыргызстане: проблемы и перспективы. Вестн. Ассоц. пульмонол. Центр. Азии 2005; 8: 8-17.
5. Global initiative for asthma. Global strategy for asthma management and prevention NHBI/WHJ workshop report. NHLBI Publ. No/95-3659.
6. Gupta R., Anderson H.R., Strachan D.P. et al. International trends in admissions and drug sales for asthma. IJTLD 2006; 10: 138-145.
7. Бримкулов Н.Н. (ред.) Руководство по ведению больных с болезнями органов дыхания для врачей первичного уровня здравоохранения на основе стратегии PAL ВОЗ. Бишкек: Илим; 2005.
8. Davis D., Evans M., Jadad A. et al. The case for knowledge translation: shortening the journey from evidence to effect. Br. Med. J. 2003; 327: 33-35.
9. Philips J.J., Stone R.D. How to measure training results. A practical guide to tracking the six key indicators. New York: McGraw Hill; 2002.
10. Mannino D.M., Gagnon R.C., Petty T.L., Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 2000; 118 (4): 981-989.
11. Thiadens H.A., De Bock G.H., Van Houwelingen J.C. et al. Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV 1 in primary care patients presenting with a persistent cough? Thorax 1999; 54: 1055-1060.
12. Ait!Khaled N., Enarson D.A., Bencharif N. et al. Implementation of asthma guidelines in health centres of several developing countries. Int. J. Tuberc. Lung Dis. 2006; 10: 104-109.
13. Rastogi D., Shetty A., Neugebauer R. et al. National Heart, Lung, and Blood Institute guidelines and asthma management practices among inner-city pediatric primary care providers. Chest 2006; 129: 619-623.
14. Laforest L., Van Ganse E., Devouassoux G. Management of asthma in patients supervised by primary care physicians or by specialists. Eur. Respir. J. 2006; 27: 42-50.
15. Kavuru M., Melamed J., Gross G. et al. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, doubleblind, placebo-controlled trial. J. Allergy Clin. Immunol. 2000; 105: 1108-1116.
16. Krishnan J.A., Riekert K.A., McCoy J.V. et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am. J. Respir. Crit. Care Med. 2004; 170 (12): 1281-1285.
17. Williams L.K., Pladevall M., Xi H. et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J. Allergy Clin. Immunol. 2004; 114: 1288-1293.
18. Fairall L.R., Zwarenstein M., Bateman E.D. et al. Effect of educational outreach to nurses on tuberculosis case detection and primary care of respiratory illness: pragmatic cluster randomized controlled trial. Brit. Med. J. 2005; 331: 750-754.